| |
| |
|
| Insider
Information: |
Mendlein John |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
926,613 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,408,154 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
926,613 |
|
|
| Total
Value |
$1,408,154 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -64.4%
|
-74.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fate Therapeutics Inc |
FATE |
Director |
2023-01-19 |
311,231 |
|
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2018-12-21 |
615,382 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2023-01-19 |
4 |
OE |
$1.37 |
$38,992 |
D/D |
28,461 |
311,231 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2023-01-13 |
4 |
B |
$5.43 |
$198,906 |
D/D |
36,631 |
282,770 |
2.39 |
% |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2023-01-11 |
4 |
B |
$5.67 |
$499,232 |
D/D |
88,048 |
246,139 |
2.39 |
% |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
8,650 |
166,741 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2022-06-03 |
4 |
S |
$22.79 |
$31,086 |
D/D |
(1,364) |
158,091 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2022-03-10 |
4 |
OE |
$1.63 |
$51,446 |
D/D |
31,562 |
191,017 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2022-03-10 |
4 |
AS |
$34.73 |
$1,105,200 |
D/D |
(31,562) |
159,455 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,681 |
159,455 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2018-12-21 |
4 |
B |
$0.42 |
$82,602 |
D/D |
195,000 |
615,382 |
2.39 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2018-12-20 |
4 |
B |
$0.41 |
$20,645 |
D/D |
50,000 |
420,382 |
2.39 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Director |
• • – |
2017-08-31 |
4 |
B |
$2.65 |
$100,000 |
D/D |
37,736 |
367,883 |
2.81 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Director |
• • – |
2017-04-24 |
4 |
AB |
$3.00 |
$372 |
D/D |
124 |
327,647 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Director |
• • – |
2017-04-20 |
4 |
AB |
$3.00 |
$4,656 |
D/D |
1,552 |
327,523 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Director |
• • – |
2017-04-18 |
4 |
AB |
$3.00 |
$3,000 |
D/D |
1,000 |
325,971 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Director |
• • – |
2016-12-19 |
4 |
B |
$2.20 |
$151,662 |
D/D |
69,000 |
324,971 |
2.81 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Director |
• • – |
2016-04-05 |
4 |
B |
$3.55 |
$8,875 |
D/D |
2,500 |
248,471 |
2.81 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Director |
• • – |
2016-04-05 |
4 |
B |
$3.52 |
$8,800 |
D/D |
2,500 |
250,971 |
2.81 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Executive Chairman |
• • – |
2015-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
24,055 |
245,971 |
0 |
- |
|
| LIFE |
aTyr Pharma Inc |
CEO and Executive ChairmanOffi |
• • – |
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
221,916 |
|
- |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2013-10-04 |
4 |
B |
$6.00 |
$100,002 |
D/D |
16,667 |
156,774 |
2.39 |
- |
|
| FATE |
Fate Therapeutics Inc |
Director |
– • – |
2013-09-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
140,107 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
